Despite rigorous cleaning, dangerous bacteria are lurking in hospital sink drains leading to a rise in ...

In the short-term, with therapeutic options dwindling, it is essential that the last remaining antimicrobials be safeguarded through rational selection and improved infection control. The ...

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

Carbapenem-resistant K. pneumoniae bloodstream infections have surged in 23 EU member states, driven by the continued spread of multidrug-resistant high-risk lineages in hospitals. Newly emerging ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a ...